Metastatic Pancreatic Cancer
Metastatic pancreatic cancer occurs when cancer that starts in the pancreas spreads to other organs, often leading to serious health issues. It is known for being aggressive and can be challenging to treat.
Pancreatic Cancer: Gembrax with Folfirinox
We are studying whether adding Gembrax to the standard Folfirinox treatment helps patients with metastatic pancreatic cancer. This trial aims to find out if the combination is more effective than Folfirinox alone.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut Godinot
Marne
Cormontreuil, France
Institut Regional Du Cancer De Montpellier
Hérault
Grabels, France
Centre Hospitalier Universitaire Grenoble Alpes
Isère
La Tronche, France
Sponsor: Institut Regional Du Cancer De Montpellier
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.